tiprankstipranks
TipRanksTop Financial ExpertsInsidersAtlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P. Insider Profile

4 Followers
Atlas Venture Fund XI, L.P., Ten Percent Owner at Akero Therapeutics, holds 9.80M shares in Third Harmonic Bio, Inc. (Ticker: THRD), holds 6.56M shares in Dyne Therapeutics (Ticker: DYN), holds 2.75M shares in Xilio Therapeutics (Ticker: XLO).
tipranks
Atlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P.
Akero Therapeutics (AKRO)
Ten Percent Owner

Ranked #86,637 out of 100,516 Corporate Insiders

Profitable Transactions

25%
2 out of 8 Profitable Transactions

Average Return

-22.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$372M
39.39%
27.08%
19.44%
12.76%
1.32% Others
A breakdown of Atlas Venture Fund XI, L.P.'s holdings

Insider Roles

Akero Therapeutics
(AKRO)
Ten Percent Owner
Dyne Therapeutics
(DYN)
Ten Percent Owner
Day One Biopharmaceuticals
(DAWN)
Ten Percent Owner
Third Harmonic Bio, Inc.
(THRD)
Ten Percent Owner
+2 other positions
Roles that Atlas Venture Fund XI, L.P. holds in companies

Most Profitable Insider Trade

Stock:
Ikena Oncology
(IKNA)
Rating:Informative Sell
Date:Dec 14, 2021 - Dec 14, 2022
Return:+80.00%
The most profitable trade made by Atlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Akero Therapeutics
Jan 02, 2020
Ten Percent Owner
Uninformative Sell
$146.71M
Dyne Therapeutics
Feb 28, 2024
Ten Percent Owner
Uninformative Sell
19.63M
$100.87M
Day One Biopharmaceuticals
Dec 14, 2022
Ten Percent Owner
Uninformative Sell
$72.40M
Xilio Therapeutics
Feb 09, 2024
Ten Percent Owner
Informative Sell
640.00
$1.87M
Ikena Oncology
Dec 14, 2021
Ten Percent Owner
Informative Buy
2.00M
$3.05M
Third Harmonic Bio, Inc.
Nov 05, 2024
Ten Percent Owner
Uninformative Sell
$47.52M
List of latest transactions for each holding click on a transaction to see Atlas Venture Fund XI, L.P.'s performance on stock

Atlas Venture Fund XI, L.P. insider profile FAQ

What is the percentage of profitable transactions made by Atlas Venture Fund XI, L.P.?
The percentage of profitable transactions made by Atlas Venture Fund XI, L.P. is 25%.
    What is the average return per transaction made by Atlas Venture Fund XI, L.P.?
    The average return per transaction made by Atlas Venture Fund XI, L.P. is -22.70%.
      What stocks does Atlas Venture Fund XI, L.P. hold?
      Atlas Venture Fund XI, L.P. holds: AKRO, DYN, DAWN, XLO, IKNA, THRD stocks.
        What was Atlas Venture Fund XI, L.P.’s latest transaction?
        Atlas Venture Fund XI, L.P. latest transaction was an Uninformative Sell of ―.
          What was Atlas Venture Fund XI, L.P.'s most profitable transaction?
          Atlas Venture Fund XI, L.P.’s most profitable transaction was an Informative Sell of IKNA stock on December 14, 2021. The return on the trade was 80.00%.
            What is Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics?
            Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.